The global equine veterinary therapeutics market is expected to expand significantly and generate revenue of US$ 2,671.9 million by 2033 from US$ 1,378.7 million in 2023. This increase in revenue is made with an impressive CAGR value of 6.8%.
Historically the equine veterinary therapeutics market is generated US$ 1,307.6 million in 2022. There is expanding popularity of horse activities like racing and jumping which makes demand for equine veterinary therapeutics for care and treatment for horses if any horse gets any injury in these activities.
Equine veterinary therapy is a broad word that covers a wide range of horse therapies. These medicines have the potential to prevent, diagnose, and cure a wide range of diseases and medical conditions.
Horse owners are investing a large amount of money in the health of their animals as they are becoming more aware of the importance of care and treatment of their horses which brings the growth of the equine veterinary therapeutics market.
Regulations governing the use of horse veterinary medications have been established by governments. These rules are intended to ensure both the security and the effectiveness of these health care products. This is predicted to support the expansion of the equine veterinary treatments market, as owners of animals will be more willing to utilize medications that have received approval from the government.
| Report Attribute | Details |
|---|---|
| Equine Veterinary Therapeutics Market Value (2023) | US$ 1,378.7 million |
| Equine Veterinary Therapeutics Market Anticipated Forecast Value (2033) | US$ 2,671.9 million |
| Equine Veterinary Therapeutics Market Projected Growth Rate (2023 to 2033) | 6.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global equine veterinary therapeutics market expanded significantly from a revenue of US$ 1,052.2 million in 2017 to US$ 1,307.6 million in 2022 with an impressive CAGR of 4.4% during the historical period 2017 to 2022.
The global equestrian sports business is quickly expanding, which is fueling demand for equine veterinarian services. Horses are utilized in many sports, such as racing, show jumping, and dressage. These activities necessitate horses in peak physical condition, which increases the demand for preventative and therapeutic veterinary services.
Innovative Growth Strategies by Key Players to Thrive in the Competition
Investment Opportunities in the Industry
North America is the largest horse veterinary treatments market, accounting for 30.7% value share in global market. It is likely to expand more in the next decade. The veterinary treatments market in North America is expanding due to increased demand for anti-infectives, vaccinations, pain medications, digestive aids, and the strong research and development industry in North America, are driving the market.
| Country | The United States |
|---|---|
| 2022 value share in Global Market | 24.7% |
The European market for horse veterinary medications is extremely fragmented and has a value share of 35.2% in 2022, with many small and medium-sized businesses. However, a few huge international corporations play a significant influence in the industry. Many Europe companies manufacture horse goods including immunizations, antibiotics, anti-inflammatory medicines, and pain medications.
| Country | United Kingdom |
|---|---|
| Value CAGR (2023 to 2033) | 4.8% |
| Country | Germany |
|---|---|
| 2022 value share in Global Market | 6.2% |
The adoption of technology is also playing a significant role in the growth of the Asia Pacific equine veterinary therapeutics market. New technologies are being developed that have the potential to transform the treatment of horse illnesses, like gene therapy, immunotherapy, and customized medicine. These technologies are projected to play a significant role in market growth in the future years in the region.
| Country | Japan |
|---|---|
| 2022 value share in Global Market | 4.4% |
| Country | Value CAGR (2023 to 2033) |
|---|---|
| China | 8.3% |
| India | 6.8% |
Principal Consultant
| Segment Name | Segment Share |
|---|---|
| Topical | 43.2 |
| Veterinary Clinics | 40.5 |
With the increased demand for anti-infectives, pain relievers, and digestive aid products, the topical section of the veterinary treatments market is expanding and has a segment share of 43.2%. The rising frequency of infectious illnesses, rising prevalence of chronic diseases, and rising pet obesity rates are all boosting demand for these items.
With rising demand for surgery, diagnostic testing, and preventive care, the veterinary clinics sector of the veterinary treatments market is expanding and has a segment share of 40.5%. The rising prevalence of animal injuries and diseases, the increased availability of diagnostic testing, and the expanding understanding of the value of preventative treatment are all boosting demand for these services.
Recent Developments
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The equine veterinary therapeutics market is expected to expand at a CAGR of 6.8% from 2023 to 2033.
North America is the leading region in the global equine veterinary therapeutics market.
The global equine veterinary therapeutics market was valued at US$ 1,378.7 million in 2023.
The anticipated revenue of the equine veterinary therapeutics market until 2033 is US$ 2,671.9 million.
Zoetis, Boehringer Ingelheim, Merck Animal Health, Virbac, Elanco Animal Health, and Ceva Animal Health are prominent market manufacturers.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drugs
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Drugs, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Drugs, 2023 to 2033
5.3.1. Anti- Inflammatory
5.3.2. Anti – Infective
5.3.3. Parasiticides
5.3.4. Others
5.4. Y-o-Y Growth Trend Analysis By Drugs, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Drugs, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Vaccines
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Vaccines, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Vaccines, 2023 to 2033
6.3.1. Recombinant vaccines
6.3.2. Inactivated Vaccines
6.3.3. Live attenuated vaccines
6.3.4. Others
6.4. Y-o-Y Growth Trend Analysis By Vaccines, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Vaccines, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Feed Additives
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Feed Additives, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Feed Additives, 2023 to 2033
7.3.1. Vitamins
7.3.2. Antibiotics
7.3.3. Amino acids
7.3.4. Enzymes
7.3.5. Others
7.4. Y-o-Y Growth Trend Analysis By Feed Additives, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Feed Additives, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Route of Administration
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By Route of Administration, 2018 to 2022
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Route of Administration, 2023 to 2033
8.3.1. Oral
8.3.2. Parental
8.3.3. Topical
8.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2018 to 2022
8.5. Absolute $ Opportunity Analysis By Route of Administration, 2023 to 2033
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
9.1. Introduction / Key Findings
9.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2018 to 2022
9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033
9.3.1. Veterinary Hospital
9.3.2. Veterinary Clinics
9.3.3. Pharmacies and drug stores
9.3.4. E-commerce
9.3.5. Other
9.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022
9.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033
10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
10.1. Introduction
10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Western Europe
10.3.4. Eastern Europe
10.3.5. South Asia and Pacific
10.3.6. East Asia
10.3.7. Middle East and Africa
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. USA
11.2.1.2. Canada
11.2.2. By Drugs
11.2.3. By Vaccines
11.2.4. By Feed Additives
11.2.5. By Route of Administration
11.2.6. By Distribution Channel
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Drugs
11.3.3. By Vaccines
11.3.4. By Feed Additives
11.3.5. By Route of Administration
11.3.6. By Distribution Channel
11.4. Key Takeaways
12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Brazil
12.2.1.2. Mexico
12.2.1.3. Rest of Latin America
12.2.2. By Drugs
12.2.3. By Vaccines
12.2.4. By Feed Additives
12.2.5. By Route of Administration
12.2.6. By Distribution Channel
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Drugs
12.3.3. By Vaccines
12.3.4. By Feed Additives
12.3.5. By Route of Administration
12.3.6. By Distribution Channel
12.4. Key Takeaways
13. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. Germany
13.2.1.2. UK
13.2.1.3. France
13.2.1.4. Spain
13.2.1.5. Italy
13.2.1.6. Rest of Western Europe
13.2.2. By Drugs
13.2.3. By Vaccines
13.2.4. By Feed Additives
13.2.5. By Route of Administration
13.2.6. By Distribution Channel
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Drugs
13.3.3. By Vaccines
13.3.4. By Feed Additives
13.3.5. By Route of Administration
13.3.6. By Distribution Channel
13.4. Key Takeaways
14. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. Poland
14.2.1.2. Russia
14.2.1.3. Czech Republic
14.2.1.4. Romania
14.2.1.5. Rest of Eastern Europe
14.2.2. By Drugs
14.2.3. By Vaccines
14.2.4. By Feed Additives
14.2.5. By Route of Administration
14.2.6. By Distribution Channel
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Drugs
14.3.3. By Vaccines
14.3.4. By Feed Additives
14.3.5. By Route of Administration
14.3.6. By Distribution Channel
14.4. Key Takeaways
15. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. India
15.2.1.2. Bangladesh
15.2.1.3. Australia
15.2.1.4. New Zealand
15.2.1.5. Rest of South Asia and Pacific
15.2.2. By Drugs
15.2.3. By Vaccines
15.2.4. By Feed Additives
15.2.5. By Route of Administration
15.2.6. By Distribution Channel
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Drugs
15.3.3. By Vaccines
15.3.4. By Feed Additives
15.3.5. By Route of Administration
15.3.6. By Distribution Channel
15.4. Key Takeaways
16. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. China
16.2.1.2. Japan
16.2.1.3. South Korea
16.2.2. By Drugs
16.2.3. By Vaccines
16.2.4. By Feed Additives
16.2.5. By Route of Administration
16.2.6. By Distribution Channel
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Drugs
16.3.3. By Vaccines
16.3.4. By Feed Additives
16.3.5. By Route of Administration
16.3.6. By Distribution Channel
16.4. Key Takeaways
17. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
17.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
17.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
17.2.1. By Country
17.2.1.1. GCC Countries
17.2.1.2. South Africa
17.2.1.3. Israel
17.2.1.4. Rest of MEA
17.2.2. By Drugs
17.2.3. By Vaccines
17.2.4. By Feed Additives
17.2.5. By Route of Administration
17.2.6. By Distribution Channel
17.3. Market Attractiveness Analysis
17.3.1. By Country
17.3.2. By Drugs
17.3.3. By Vaccines
17.3.4. By Feed Additives
17.3.5. By Route of Administration
17.3.6. By Distribution Channel
17.4. Key Takeaways
18. Key Countries Market Analysis
18.1. USA
18.1.1. Pricing Analysis
18.1.2. Market Share Analysis, 2022
18.1.2.1. By Drugs
18.1.2.2. By Vaccines
18.1.2.3. By Feed Additives
18.1.2.4. By Route of Administration
18.1.2.5. By Distribution Channel
18.2. Canada
18.2.1. Pricing Analysis
18.2.2. Market Share Analysis, 2022
18.2.2.1. By Drugs
18.2.2.2. By Vaccines
18.2.2.3. By Feed Additives
18.2.2.4. By Route of Administration
18.2.2.5. By Distribution Channel
18.3. Brazil
18.3.1. Pricing Analysis
18.3.2. Market Share Analysis, 2022
18.3.2.1. By Drugs
18.3.2.2. By Vaccines
18.3.2.3. By Feed Additives
18.3.2.4. By Route of Administration
18.3.2.5. By Distribution Channel
18.4. Mexico
18.4.1. Pricing Analysis
18.4.2. Market Share Analysis, 2022
18.4.2.1. By Drugs
18.4.2.2. By Vaccines
18.4.2.3. By Feed Additives
18.4.2.4. By Route of Administration
18.4.2.5. By Distribution Channel
18.5. Germany
18.5.1. Pricing Analysis
18.5.2. Market Share Analysis, 2022
18.5.2.1. By Drugs
18.5.2.2. By Vaccines
18.5.2.3. By Feed Additives
18.5.2.4. By Route of Administration
18.5.2.5. By Distribution Channel
18.6. UK
18.6.1. Pricing Analysis
18.6.2. Market Share Analysis, 2022
18.6.2.1. By Drugs
18.6.2.2. By Vaccines
18.6.2.3. By Feed Additives
18.6.2.4. By Route of Administration
18.6.2.5. By Distribution Channel
18.7. France
18.7.1. Pricing Analysis
18.7.2. Market Share Analysis, 2022
18.7.2.1. By Drugs
18.7.2.2. By Vaccines
18.7.2.3. By Feed Additives
18.7.2.4. By Route of Administration
18.7.2.5. By Distribution Channel
18.8. Spain
18.8.1. Pricing Analysis
18.8.2. Market Share Analysis, 2022
18.8.2.1. By Drugs
18.8.2.2. By Vaccines
18.8.2.3. By Feed Additives
18.8.2.4. By Route of Administration
18.8.2.5. By Distribution Channel
18.9. Italy
18.9.1. Pricing Analysis
18.9.2. Market Share Analysis, 2022
18.9.2.1. By Drugs
18.9.2.2. By Vaccines
18.9.2.3. By Feed Additives
18.9.2.4. By Route of Administration
18.9.2.5. By Distribution Channel
18.10. Poland
18.10.1. Pricing Analysis
18.10.2. Market Share Analysis, 2022
18.10.2.1. By Drugs
18.10.2.2. By Vaccines
18.10.2.3. By Feed Additives
18.10.2.4. By Route of Administration
18.10.2.5. By Distribution Channel
18.11. Russia
18.11.1. Pricing Analysis
18.11.2. Market Share Analysis, 2022
18.11.2.1. By Drugs
18.11.2.2. By Vaccines
18.11.2.3. By Feed Additives
18.11.2.4. By Route of Administration
18.11.2.5. By Distribution Channel
18.12. Czech Republic
18.12.1. Pricing Analysis
18.12.2. Market Share Analysis, 2022
18.12.2.1. By Drugs
18.12.2.2. By Vaccines
18.12.2.3. By Feed Additives
18.12.2.4. By Route of Administration
18.12.2.5. By Distribution Channel
18.13. Romania
18.13.1. Pricing Analysis
18.13.2. Market Share Analysis, 2022
18.13.2.1. By Drugs
18.13.2.2. By Vaccines
18.13.2.3. By Feed Additives
18.13.2.4. By Route of Administration
18.13.2.5. By Distribution Channel
18.14. India
18.14.1. Pricing Analysis
18.14.2. Market Share Analysis, 2022
18.14.2.1. By Drugs
18.14.2.2. By Vaccines
18.14.2.3. By Feed Additives
18.14.2.4. By Route of Administration
18.14.2.5. By Distribution Channel
18.15. Bangladesh
18.15.1. Pricing Analysis
18.15.2. Market Share Analysis, 2022
18.15.2.1. By Drugs
18.15.2.2. By Vaccines
18.15.2.3. By Feed Additives
18.15.2.4. By Route of Administration
18.15.2.5. By Distribution Channel
18.16. Australia
18.16.1. Pricing Analysis
18.16.2. Market Share Analysis, 2022
18.16.2.1. By Drugs
18.16.2.2. By Vaccines
18.16.2.3. By Feed Additives
18.16.2.4. By Route of Administration
18.16.2.5. By Distribution Channel
18.17. New Zealand
18.17.1. Pricing Analysis
18.17.2. Market Share Analysis, 2022
18.17.2.1. By Drugs
18.17.2.2. By Vaccines
18.17.2.3. By Feed Additives
18.17.2.4. By Route of Administration
18.17.2.5. By Distribution Channel
18.18. China
18.18.1. Pricing Analysis
18.18.2. Market Share Analysis, 2022
18.18.2.1. By Drugs
18.18.2.2. By Vaccines
18.18.2.3. By Feed Additives
18.18.2.4. By Route of Administration
18.18.2.5. By Distribution Channel
18.19. Japan
18.19.1. Pricing Analysis
18.19.2. Market Share Analysis, 2022
18.19.2.1. By Drugs
18.19.2.2. By Vaccines
18.19.2.3. By Feed Additives
18.19.2.4. By Route of Administration
18.19.2.5. By Distribution Channel
18.20. South Korea
18.20.1. Pricing Analysis
18.20.2. Market Share Analysis, 2022
18.20.2.1. By Drugs
18.20.2.2. By Vaccines
18.20.2.3. By Feed Additives
18.20.2.4. By Route of Administration
18.20.2.5. By Distribution Channel
18.21. GCC Countries
18.21.1. Pricing Analysis
18.21.2. Market Share Analysis, 2022
18.21.2.1. By Drugs
18.21.2.2. By Vaccines
18.21.2.3. By Feed Additives
18.21.2.4. By Route of Administration
18.21.2.5. By Distribution Channel
18.22. South Africa
18.22.1. Pricing Analysis
18.22.2. Market Share Analysis, 2022
18.22.2.1. By Drugs
18.22.2.2. By Vaccines
18.22.2.3. By Feed Additives
18.22.2.4. By Route of Administration
18.22.2.5. By Distribution Channel
18.23. Israel
18.23.1. Pricing Analysis
18.23.2. Market Share Analysis, 2022
18.23.2.1. By Drugs
18.23.2.2. By Vaccines
18.23.2.3. By Feed Additives
18.23.2.4. By Route of Administration
18.23.2.5. By Distribution Channel
19. Market Structure Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Market Share Analysis of Top Players
19.3.1. By Regional
19.3.2. By Drugs
19.3.3. By Vaccines
19.3.4. By Feed Additives
19.3.5. By Route of Administration
19.3.6. By Distribution Channel
20. Competition Analysis
20.1. Competition Deep Dive
20.1.1. Merck Animal Heath
20.1.1.1. Overview
20.1.1.2. Product Portfolio
20.1.1.3. Profitability by Market Segments
20.1.1.4. Sales Footprint
20.1.1.5. Strategy Overview
20.1.1.5.1. Marketing Strategy
20.1.2. Affymetrix
20.1.2.1. Overview
20.1.2.2. Product Portfolio
20.1.2.3. Profitability by Market Segments
20.1.2.4. Sales Footprint
20.1.2.5. Strategy Overview
20.1.2.5.1. Marketing Strategy
20.1.3. Elanco Animal Health
20.1.3.1. Overview
20.1.3.2. Product Portfolio
20.1.3.3. Profitability by Market Segments
20.1.3.4. Sales Footprint
20.1.3.5. Strategy Overview
20.1.3.5.1. Marketing Strategy
20.1.4. Zoetis (Pfizer Animal Health)
20.1.4.1. Overview
20.1.4.2. Product Portfolio
20.1.4.3. Profitability by Market Segments
20.1.4.4. Sales Footprint
20.1.4.5. Strategy Overview
20.1.4.5.1. Marketing Strategy
20.1.5. Equine Health UK
20.1.5.1. Overview
20.1.5.2. Product Portfolio
20.1.5.3. Profitability by Market Segments
20.1.5.4. Sales Footprint
20.1.5.5. Strategy Overview
20.1.5.5.1. Marketing Strategy
20.1.6. Olympia Equine Veterinary Services PLLC
20.1.6.1. Overview
20.1.6.2. Product Portfolio
20.1.6.3. Profitability by Market Segments
20.1.6.4. Sales Footprint
20.1.6.5. Strategy Overview
20.1.6.5.1. Marketing Strategy
20.1.7. Ceva Sante Animale
20.1.7.1. Overview
20.1.7.2. Product Portfolio
20.1.7.3. Profitability by Market Segments
20.1.7.4. Sales Footprint
20.1.7.5. Strategy Overview
20.1.7.5.1. Marketing Strategy
20.1.8. Eli Lilly and Company
20.1.8.1. Overview
20.1.8.2. Product Portfolio
20.1.8.3. Profitability by Market Segments
20.1.8.4. Sales Footprint
20.1.8.5. Strategy Overview
20.1.8.5.1. Marketing Strategy
20.1.9. Virbac
20.1.9.1. Overview
20.1.9.2. Product Portfolio
20.1.9.3. Profitability by Market Segments
20.1.9.4. Sales Footprint
20.1.9.5. Strategy Overview
20.1.9.5.1. Marketing Strategy
20.1.10. Bayer AG
20.1.10.1. Overview
20.1.10.2. Product Portfolio
20.1.10.3. Profitability by Market Segments
20.1.10.4. Sales Footprint
20.1.10.5. Strategy Overview
20.1.10.5.1. Marketing Strategy
21. Assumptions & Acronyms Used
22. Research Methodology
Explore Healthcare Insights
View Reports
Equine Veterinary Therapeutics Market
